Lipid composition heatmap for Study ST003431

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:CAL120 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:HCC1806 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:HS578T breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:MCF7 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:MDA-MB-231 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:MDA-MB-468 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA
Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM GSK214069
Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate
Sample source:SUM159PT breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 mM dimethylmalonate + 1 uM GSK214069
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines11
Saturated FA6
Unsaturated FA1
  logo